How to buy National Research stock (NRC)

National Research is a health information services business based in the US. National Research shares (NRC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $17.18 – a decrease of 6.98% over the previous week. National Research employs 435 staff and has a trailing 12-month revenue of around $144.2 million.

Our top picks for where to buy National Research stock

Buy National Research stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

National Research stock price (NASDAQ: NRC)

Use our graph to track the performance of NRC stocks over time.

National Research shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$17.18
52-week range	$16.93 - $41.61
50-day moving average more info button	$19.08
200-day moving average more info button	$25.82
Wall St. target price	N/A
PE ratio more info button	15.3393
Dividend yield more info button	$0.48 (2.8%)
Earnings per share (TTM) more info button	$1.12

Is it a good time to buy National Research stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

National Research price performance over time

Historical closes compared with the close of $17.68 from 2024-12-17

1 week (2024-12-12)	-4.28%
1 month (2024-11-19)	-6.11%
3 months (2024-09-19)	-19.45%
6 months (2024-06-18)	-29.62%

1 year (2023-12-19)	-55.26%
2 years (2022-12-19)	-50.45%
3 years (2021-12-17)	39.2154
5 years (2019-12-19)	59.7674

Is National Research stock undervalued or overvalued?

Valuing National Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of National Research's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

National Research's P/E ratio

National Research's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, National Research shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

National Research's EBITDA

National Research's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $43.3 million.

The EBITDA is a measure of a National Research's overall financial performance and is widely used to measure a its profitability.

National Research financials

Revenue TTM	$144.2 million
Operating margin TTM	22.29%
Gross profit TTM	$94.5 million
Return on assets TTM	18.53%
Return on equity TTM	58.56%
Profit margin	18.79%
Book value	$1.48
Market Capitalization more info button	$403.3 million

TTM: trailing 12 months

National Research share dividends

Dividend payout ratio: 42.74% of net profits

Recently National Research has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), National Research shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In National Research's case, that would currently equate to about $0.48 per share.

While National Research's payout ratio might seem fairly standard, it's worth remembering that National Research may be investing much of the rest of its net profits in future growth.

National Research's most recent dividend payout was on 9 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 26 December 2024 (the "ex-dividend date").

National Research share price volatility

Over the last 12 months, National Research's shares have ranged in value from as little as $16.925 up to $41.608. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while National Research's is 0.532. This would suggest that National Research's shares are less volatile than average (for this exchange).

National Research overview

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. .

Frequently asked questions

What percentage of National Research is owned by insiders or institutions?
Currently 37.38% of National Research shares are held by insiders and 52.021% by institutions. How many people work for National Research?
Latest data suggests 435 work at National Research. When does the fiscal year end for National Research?
National Research's fiscal year ends in December. Where is National Research based?
National Research's address is: 1245 Q Street, Lincoln, NE, United States, 68508 What is National Research's ISIN number?
National Research's international securities identification number is: US6373722023 What is National Research's CUSIP number?
National Research's Committee on Uniform Securities Identification Procedures number is: 637372103